Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Interferon-β-1b: a review of its use in multiple sclerosis.
The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets.
Tolerability and Pulmonary Pharmacodynamic Effects During Treatment Initiation of Once-Daily Oral Fingolimod in Subjects With Moderate Asthma.
Risks of immune system treatments.
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Oracle Cladribine in Early Multiple Sclerisis (MS) (ORACLE MS)
Gpr126 is essential for peripheral nerve development and myelination in mammals.
New data from ENDORSE show positive results continued over five years with TECFIDERA® (dimethyl fumarate) in a wide range of multiple sclerosis patients
American Society for Cell Biology Annual Meeting
Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical Trial.
Gene expression analysis reveals functional pathways of glatiramer acetate activation.
Gordon Research Conference on Immunochemistry & Immunobiology
Multiple sclerosis: A lifestyle disease?
Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.
Nephrotic Syndrome in a Multiple Sclerosis Patient Receiving Long-term Interferon Beta Therapy.
Glatiramer acetate biases dendritic cells towards an anti-inflammatory phenotype by modulating OPN, IL-17, and RORγt responses and by increasing IL-10 production in experimental allergic encephalomyelitis.
Autoimmunity in visual loss.
One calcitriol dose transiently increases Helios(+)FoxP3(+) T cells and ameliorates autoimmune demyelinating disease.
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
Thrombotic microangiopathy associated with use of interferon-beta.
Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis.
Use of amiloride and multiple sclerosis: registry-based cohort studies.
Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies.
Society for Neuroscience Annual Meeting
Reversible cerebral vasoconstriction syndrome associated with interferon beta-1a use for multiple sclerosis.

Pages